Cardiovascular Implantable Electronic Devices (CIEDs), that is implantable cardioverter defibrillators, pacemakers and implantable cardiac monitors are first-line tools for the therapeutic or diagnostic management of cardiac rhythm disorders. After CIEDs implantation, regular follow-up of these medical devices is required to evaluate the device integrity, to interrogate the device for recorded arrhythmias, and possibly to reprogram the device. Remote monitoring (RM) of CIEDs is an important alternative to in-office follow-up of these medical devices by offering continuous surveillance of both CIEDs and patients, in order to improve the safety and costeffective delivery of health care. [1] [2] [3] Nowadays, RM could further enhance patients' safety by achieving the required social distancing due to the COVID-19 pandemic. In a recent update (April 15, 2020), the Heart Rhythm Society (HRS) Task Force on the management of CIEDs urged health care professionals that "Every effort should be made to perform CIED interrogation via remote monitoring rather than in-person visits". 